Proprietary AI analyst is now available
- Public Comps
- Mirion
Mirion Valuation Multiples
Discover Mirion's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like FLSmidth, Cochlear, Hiab, Georg Fischer and more.
Mirion Overview
About Mirion
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
Founded
2018
HQ

Employees
3.3K
Website
Financials (LTM)
EV
$5B
Valuation Multiples
Start free trialMirion Financials
Mirion reported last 12-month revenue of $1B and EBITDA of $254M.
In the same LTM period, Mirion generated $485M in gross profit, $254M in EBITDA, and $133M in net income.
Revenue (LTM)
Mirion P&L
In the most recent fiscal year, Mirion reported revenue of $925M and EBITDA of $228M.
Mirion is profitable as of last fiscal year, with gross margin of 47%, EBITDA margin of 25%, and net margin of 13%.
Financial data powered by Morningstar, Inc.
Mirion Stock Performance
Mirion has current market cap of $4B, and enterprise value of $5B.
Market Cap Evolution
Mirion's stock price is $18.22.
Mirion share price decreased by 0.3% in the last 30 days, and by 17.7% in the last year.
Mirion has an EPS (earnings per share) of $0.49.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $4B | -0.1% | -0.3% | -2.0% | -17.7% | $0.49 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMirion Valuation Multiples
Mirion trades at 5.2x EV/Revenue multiple, and 20.8x EV/EBITDA.
EV / Revenue (LTM)
Mirion Financial Valuation Multiples
As of June 5, 2026, Mirion has market cap of $4B and EV of $5B.
Mirion has a P/E ratio of 33.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Mirion Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Mirion Margins & Growth Rates
Mirion grew revenue by 23% and EBITDA by 27% in the last fiscal year.
In the most recent fiscal year, Mirion reported gross margin of 47%, EBITDA margin of 25%, and net margin of 13%.
Mirion Margins
Mirion Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Mirion Operational KPIs
Mirion's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Mirion's Rule of 40 is 49% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mirion's Rule of X is 83% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Mirion Competitors
Mirion competitors include FLSmidth, Cochlear, Hiab, Georg Fischer, Imeik Technology Development, Xometry, Rigaku, DMG Mori, Canon Marketing Japan and Fuji.
Most Mirion public comparables operate across Machinery, Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.1x | 2.1x | 11.7x | 11.0x | |||
| 2.7x | 2.7x | 10.1x | 12.9x | |||
| 2.3x | 2.2x | 13.3x | 13.1x | |||
| 1.2x | 1.3x | 8.9x | 10.0x | |||
| 10.5x | 10.1x | 16.4x | 17.1x | |||
| 6.8x | 6.1x | 252.8x | 134.0x | |||
| 7.5x | 7.3x | 32.3x | 30.6x | |||
| 1.6x | - | 10.5x | - | |||
This data is available for Pro users. Sign up to see all Mirion competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Mirion
Mirion has acquired 9 companies to date.
Last acquisition by Mirion was on September 24th 2025. Mirion acquired Paragon for $585M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Mirion
| Description | Paragon is a supplier of instrumentation, controls, and replacement parts to the nuclear power generation industry across the U.S. Based in Fort Worth, Texas, the company provides HIPS human interface protection systems and CoreVision monitoring for plants like Comanche Peak and South Texas Project. Paragon conducts qualification testing per EPRI guidelines and operates an online marketplace for obsolete components from Westinghouse and GE designs. | Certrec is a Mineral Wells-headquartered provider of digital regulatory compliance platforms for nuclear, fossil, and renewable energy operators. The company delivers the TRAC platform for centralized documentation management and the Online Workspace for workflow automation, audit preparation, and real-time evidence tracking. Its solutions address NERC, NRC, and FERC standards through licensing support, cyber security tools, and compliance monitoring. Founded in 1987, Certrec offers managed services and expert advisory to utilities across North America, enabling plant operators and compliance teams to reduce risks during inspections. | Computerized Imaging Reference Systems is a manufacturer of anthropomorphic phantoms for medical imaging and radiation therapy quality assurance. Producing over 200 models simulating human tissues with materials mimicking bone densities from 800-2000 HU, it supplies CT, MRI, and ultrasound phantoms to hospitals worldwide. Norfolk-based since 1987, CIRS holds ISO 13485 certification and partners with Siemens Healthineers. | Dosimetry Badge is a U.S.-based distributor of OSL and TLD radiation monitoring badges for compliance with NRC and OSHA regulations. Serving hospitals, dental offices, vets, and industrial sites, it offers quarterly processing, instant reads, and expert consultations from Landauer-partnered labs. Headquartered in Texas, the service includes custom reporting and training. | |
| HQ Country | |||||
| HQ City | Greensboro, NC | Fort Worth, TX | Norfolk, VA | - | |
| Deal Date | 24 Sep 2025 | 31 Jul 2025 | 11 Nov 2021 | 4 Oct 2021 | |
| Valuation | $585M | $81M | $54M | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Mirion acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Mirion
| When was Mirion founded? | Mirion was founded in 2018. |
| Where is Mirion headquartered? | Mirion is headquartered in United States. |
| How many employees does Mirion have? | As of today, Mirion has over 3K employees. |
| Who is the CEO of Mirion? | Mirion's CEO is Thomas D. Logan. |
| Is Mirion publicly listed? | Yes, Mirion is a public company listed on NYSE. |
| What is the stock symbol of Mirion? | Mirion trades under MIR ticker. |
| When did Mirion go public? | Mirion went public in 2020. |
| Who are competitors of Mirion? | Mirion main competitors include FLSmidth, Cochlear, Hiab, Georg Fischer, Imeik Technology Development, Xometry, Rigaku, DMG Mori, Canon Marketing Japan, Fuji. |
| What is the current market cap of Mirion? | Mirion's current market cap is $4B. |
| What is the current revenue of Mirion? | Mirion's last 12 months revenue is $1B. |
| What is the current revenue growth of Mirion? | Mirion revenue growth (NTM/LTM) is 16%. |
| What is the current EV/Revenue multiple of Mirion? | Current revenue multiple of Mirion is 5.2x. |
| What is the current EBITDA of Mirion? | Mirion's last 12 months EBITDA is $254M. |
| What is Mirion's EBITDA margin? | Mirion's last 12 months EBITDA margin is 25%. |
| What is the current EV/EBITDA multiple of Mirion? | Current EBITDA multiple of Mirion is 20.8x. |
| What is the current FCF of Mirion? | Mirion's last 12 months FCF is $141M. |
| What is Mirion's FCF margin? | Mirion's last 12 months FCF margin is 14%. |
| What is the current EV/FCF multiple of Mirion? | Current FCF multiple of Mirion is 37.4x. |
| How many companies Mirion has acquired to date? | As of June 2026, Mirion has acquired 9 companies. |
| What was the largest acquisition by Mirion? | $585M acquisition of Paragon on 24th September 2025 was the largest M&A Mirion has done to date. |
| What companies Mirion acquired? | Mirion acquired Paragon, Canberra Industries, Sun Nuclear, Certrec, Computerized Imaging Reference Systems, Biodex Medical Systems, Capintec, Dosimetrics, and Dosimetry Badge. |
| In how many companies Mirion has invested to date? | Mirion hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Mirion
Lists including Mirion
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
